Eduardo Vidal Blanco

Eduardo Vidal Blanco currently serves as the Chief Executive Officer at Cathaid Inc. since January 2024, focusing on commercial and manufacturing strategy for the CA55 Engineered Securement Device. Prior to this, Eduardo held several notable positions including Founder and Chief Operating Officer at SRNA Consulting, LLC, and Head of Patient Services at Novartis where management of Patient Support Programs and strategic projects during COVID were key responsibilities. Experience also includes roles such as Chief of Staff for the Cardio, Renal & Metabolic Global Unit at Novartis, and Global Head of Strategic Planning and Project Management Office, implementing quality governance across manufacturing sites. Earlier in the career, roles in quality management at OPTIMOLD LIMITED, project engineering at MICROSYSTEMS UK, and process engineering at Eli Lilly were undertaken. Eduardo holds a Master of Science in Nanotechnology and Microsystems from Cranfield University and a Master of Engineering in Industrial Engineering from Universidad Politécnica de Madrid.